A protein that contribute to cognitive decline
( drug that blocks gamma-secretase )
Please Help Support Alzheimer's Research Today!
Your Alzheimer's donation will help billions live without it.
DONATE NOW
Your Alzheimer's donation will help billions live without it.
DONATE NOW
Reducing a protein called beta-amyloid in young mice with a condition resembling Down syndrome improves their ability to learn, researchers at UT Southwestern Medical Center have found. "This preliminary study in the animal model raises the intriguing possibility that drugs that lower beta-amyloid levels might offer some benefit to children with Down syndrome," said Dr. Craig Powell, assistant professor of neurology at UT Southwestern and co-lead author of the study, which is available in PLoS One, the Public Library of Science's online journal.
Down syndrome, a genetic disease that causes learning disabilities and physical problems, is caused by an extra copy of chromosome 21. This chromosome includes the genes for proteins that produce beta-amyloid, a protein that accumulates in the brains of people with Alzheimer's disease and is believed to contribute to cognitive decline. Children with Down syndrome have increased normal levels of beta-amyloid in their brains, but it is unknown whether the increased levels affect intellectual abilities, Dr. Powell said. By age 40, nearly all adults with Down syndrome develop signs of Alzheimer's, with dementia developing in their 50s and 60s.
For the study, the researchers used mice with a genetic anomaly that closely mimics human Down syndrome. This type of mice have three copies of a stretch of genes, including those related to beta-amyloid production, and also display learning disabilities, including difficulties learning a standard water maze. Read more: redorbit.com
Pectin show health and wellness potential
Pectin extracted from kiwifruit may boost the levels of beneficial bacteria in the gut and may also be used to microencapsulate probiotics for the health and wellness segment, suggests new research. Read more: nutraingredients.com
No comments:
Post a Comment